Home    Help    Cart    Login
Get Free Updates on Industry Research and Analysis!


Search all reports:
 Go 


Pharma and Biotech News


Marketing Services
Interested in marketing your information product through us? Email us at helpdesk AT pharma-reports.com

or call 800-304-0345




Topic Suggestion?


 Item Detail
Item Detail
You're Here: Biotech



Cord Blood Banking - A Competitive Analysis of the Industry

Select Your Format:
Price: $3,295.00
Shipping: US:  $50.00 
Non-US  $70.00
QTY:
Print Order form to pay by check
Choices in Cord Blood Banking - Factors Influencing Parental Decision-Making
Choices in Cord Blood Banking - Factors Influencing Parental Decision-Making
BioInformant

Cord blood banking is increasingly being used to improve and save lives. Stem cells derived from umbilical blood have been used in more than 14,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer.

However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows that a third of expectant parents are unaware of the option to preserve cord blood. Of the two-thirds who have some knowledge, 74% describe themselves as "minimally informed."

Part 1 of this market report used proprietary data-derivation techniques to analyze conditions of the Cord Blood Banking Industry. Part 2 of this report used an end-user survey of expectant parents to identify and analyze the factors involved in the decision to privately store, publicly donate, or discard cord blood at birth. More than 1,200 expectation parents answered the detailed survey. The survey initially focused on U.S. respondents, but due to international interest was expanded to include respondents from Canada, Mexico, South America, Europe, Asia, Australia, and other regions as well.

Key findings of the report includes:

- Rates of awareness by gender, income, geographic location, and education

- Sources through which expectant parents learn of cord blood preservation

- Factors influencing private vs. public storage of cord blood

- Price sensitivity and quality expectations

- Approaches for communicating with expectant parents

- Key factors influencing the decision to store cord blood

- Parental responsiveness to health statistics

- Trends in cord blood banking

- Competitive analysis of the cord blood banking industry





Table of Contents



182 pages

Publication Date : April 2009
 Options
Options
Select Your Format:
 Your Price
Your Price
Price: $3,295.00
Shipping: US:  $50.00 Non-US  $70.00
 QTY: 

Print Order form to pay by check


 Related Items
Related Items
Opportunities in Human Embryonic Stem Cell (hESC) Products Opportunities in Human Embryonic Stem Cell (hESC) Products

Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. They are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body, providing tremendous therapeutic potential. Human ESCs were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R.  (MORE)
Stem Cell Research Products: Opportunities, Tools & Technologies Stem Cell Research Products: Opportunities, Tools & Technologies

Since 2001, funding for research on embryonic stem cells has been extremely limited. However, on March 9, 2009, President Obama overturned the order signed by President Bush in 2001 that barred the NIH from funding research on embryonic stem cells beyond using 60 cell lines that existed at that time.  (MORE)
 

Return policy: We do accept hard copy books if a reason is included. Electronic products including
CD-ROMs and PDF files are non-returnable/non-refundable due to the duplicable nature of these products.

To market your reports, contact us at 800-304-0345 or email
Helpdesk AT PharmaReports DOT com